South Korean Pharmaceuticals & Biotech Stable Growth Stocks

ALTEOGEN

Market Cap: ₩17.9t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Samsung BiologicsLtd

Market Cap: ₩73.0t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

PharmaResearch

Market Cap: ₩4.6t

Operates as a biopharmaceutical company primarily in South Korea.

Hugel

Market Cap: ₩3.3t

Develops and manufactures biopharmaceuticals in South Korea and internationally.